Point72 Asset Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-251,823
Closed -$21M 1932
2024
Q4
$21M Buy
251,823
+131,961
+110% +$11M 0.05% 375
2024
Q3
$8.77M Sell
119,862
-434,324
-78% -$31.8M 0.02% 524
2024
Q2
$38M Buy
554,186
+380,420
+219% +$26.1M 0.1% 250
2024
Q1
$12M Buy
+173,766
New +$12M 0.03% 547
2023
Q3
Sell
-25,121
Closed -$1.59M 2246
2023
Q2
$1.59M Sell
25,121
-209,008
-89% -$13.2M ﹤0.01% 823
2023
Q1
$12.7M Buy
234,129
+39,977
+21% +$2.16M 0.04% 439
2022
Q4
$10.3M Sell
194,152
-461,648
-70% -$24.4M 0.03% 496
2022
Q3
$30.5M Buy
+655,800
New +$30.5M 0.12% 216
2020
Q4
Sell
-555,643
Closed -$14.3M 1117
2020
Q3
$14.3M Buy
+555,643
New +$14.3M 0.07% 320
2019
Q4
Sell
-559,900
Closed -$4.18M 1256
2019
Q3
$4.18M Buy
+559,900
New +$4.18M 0.03% 451
2019
Q2
Hold
0
1453
2019
Q1
Sell
-300,352
Closed -$3.42M 1154
2018
Q4
$3.42M Sell
300,352
-334,114
-53% -$3.81M 0.02% 548
2018
Q3
$13.8M Buy
634,466
+444,609
+234% +$9.65M 0.06% 299
2018
Q2
$3.36M Sell
189,857
-40,637
-18% -$718K 0.01% 548
2018
Q1
$4.85M Sell
230,494
-219,506
-49% -$4.62M 0.02% 467
2017
Q4
$6.52M Buy
450,000
+189,300
+73% +$2.74M 0.03% 440
2017
Q3
$4.11M Buy
+260,700
New +$4.11M 0.02% 472
2016
Q4
Sell
-153,300
Closed -$2.34M 806
2016
Q3
$2.34M Sell
153,300
-16,000
-9% -$244K 0.02% 502
2016
Q2
$6.57M Sell
169,300
-61,300
-27% -$2.38M 0.04% 348
2016
Q1
$6.41M Buy
230,600
+66,400
+40% +$1.85M 0.05% 351
2015
Q4
$8.83M Buy
164,200
+139,900
+576% +$7.52M 0.07% 300
2015
Q3
$973K Sell
24,300
-89,800
-79% -$3.6M 0.01% 567
2015
Q2
$3.65M Buy
114,100
+24,277
+27% +$776K 0.03% 456
2015
Q1
$2.15M Buy
+89,823
New +$2.15M 0.01% 510